Page 63 - product-manual
P. 63

TM/MC  TM/MC
             PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





                               D-Glucosamine sulphate (C H NO .H SO )
                                                                6
                                                                   13
                                                                            2
                                                                                 4
                                                                         5
                               Clinical  studies  show that  glucosamine  sulphate  and  chondroitin  sulphate  have  a  positive
                               clinical effect in dogs with osteoarthritis (McCarthy et al., 2007). A placebo-controlled study
                               demonstrated that daily treatment of arthritic dogs with glucosamine sulphate and chondroitin
                               sulphate markedly alleviated arthritic-associated pain, was well tolerated and exhibited no side
                               effects  (D’Altilio  et  al.,  2007).  A  systematic  review  of  clinical  trials  of  various  treatments
                               for  osteoarthritis in dogs using FDA’s evidence-based medicine scoring system found that a
                               moderate level of comfort was observed by using a combination of glucosamine hydrochloride
                               and chondroitin sulphate (Aragon et al., 2007). Glucosamine sulphate and chondroitin sulphate
                               have exhibited pain-relieving and activity-enhancing effects in cats with painful, mobility-impairing
                               degenerative joint disease (Lascelles et al., 2010).


                               Note:
                               The hydrochloride form of glucosamine is fermented corn-derived glucose and this may not be a preferred form (Stargrove, et al.,
                               2008).




            TOXICOLOGY  Toxicity for glucosamine sulphate has not been documented in dogs and cats when administered orally in

                therapeutic doses. The LD  of glucosamine sulphate has not been determined. No mortality in mice and rats
                                       50
                was observed at a dose of 5,000 mg/kg PO, 3,000 mg/kg IM, and 1500 mg/kg IV (Senin et al., 1987).




                        DRUG     Validated interactions studies do not exist for glucosamine sulphate preparations. A potential
                INTERACTIONS     interaction exists between the anticoagulant drug warfarin and glucosamine-chondroitin that is
                                 associated with an increase in the international normal ratio [INR] (Knudsen & Sokol, 2008).





        Methylsulfonylmethane [MSM] (C H O S)
                                                  6
                                               2
                                                     2
        MSM, also known as dimethyl  sulfone and methyl  sulfone, is an organosulfur compound
        that occurs naturally in a variety of fruits, vegetables, grains, and animals including humans.
        Clinical evidence for the usefulness of MSM consists of published studies on both animals and
        humans, and these studies have suggested some benefits in the treatment of osteoarthritis. After
        several reports that MSM helped arthritis in animal models, a double-blind, placebo-controlled
        human study suggested that 500 mg three times per day of MSM (alone or in combination with
        glucosamine sulphate 500 mg) was helpful in relieving symptoms of knee osteoarthritis (Usha
        & Naidu, 2004).










        2  |   Articulare-VM TM
   58   59   60   61   62   63   64   65   66   67   68